Navigation Links
DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008
Date:3/16/2009

ourth quarter," continued Mr. Merk. "Like many businesses today, our 2009 financial results rely significantly on how the current economy impacts our clients, and their ability to continue existing trials and contract for new business; a sentiment which is reflected in the explanatory paragraph in our Form 10-K. In Japan, our value added reseller, NTT DATA Company, has just begun the second year of our $2.1 million 5-year agreement and has already sold 8 trials to 4 different clients. This is just another example of the power of our software in a fragile world economy. While raising additional capital may be a possible avenue in 2009, our improved performance, coupled with our virtually debt-free balance sheet, makes DATATRAK a much stronger company financially then it was twelve months ago."

In addition, the Company announced that Mr. Matt Delaney, DATATRAK's Interim President since May 2008, has decided to step down from his position with the Company to pursue other opportunities. Mr. Birch commented, "We want to thank Matt for his contribution through this evolutional period in DATATRAK's operating history. We wish him well in his future endeavors."

About DATATRAK International, Inc.

DATATRAK International, Inc. is a worldwide technology company focused on the provision of multi-component eClinical solutions and related services for the clinical trials industry. The Company delivers a complete portfolio of software products that were created in order to accelerate clinical research data from investigative sites to clinical trial sponsors and ultimately the FDA, faster and more efficiently than manual methods or loosely integrated technologies. DATATRAK's eClinical software suite can be deployed worldwide through an ASP offering or in a licensed Enterprise Transfer model that fully empowers its clients. The DATATRAK software suite and its earlier versions have successfully supported hundreds of
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. DATATRAK International, Inc. Announces the Return of Chris Wilke as Vice-President of R&D and the Issuance of a Patent
2. DATATRAK Announces Retirement of Chief Executive Officer
3. DATATRAK International, Inc. Receives Notice from NASDAQ
4. NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan
5. DATATRAK International, Inc. Announces 2008 Third Quarter and Nine Month Operating Results
6. DATATRAK International Management to Host Conference Call on November 6, 2008 to Discuss Third Quarter and Nine Month Operating Results for 2008
7. DATATRAK International, Inc. Receives Notice From Nasdaq
8. Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies
9. DATATRAK Announces Restructured Senior Management Team
10. DATATRAK International Reports Fourth Quarter and Full Year Results for 2007
11. DATATRAK International Management to Host Conference Call on February 26, 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...WASHINGTON, Nov. 21 Ton... proceed to Senator Reid,s version of the governme...ctionable items included in this bill; like the pu...the government funding for elective abortion, whic...dditionally the bill provides subsidies for privat...
(Date:11/21/2009)...NEW YORK, Nov. 21 Milvia Lopez, by... City, recently filed suit, in Supreme Court, New ...laint alleges that while Ms. Lopez underwent a rou.... VINCENT,S HOSPITAL , doctors used an HIV infecte... alleges that several hours after being discharged...
(Date:11/21/2009)... LONDON, November 21, 2009 /PRNewswire-FirstCall/...est Test Test Test Test Test Test Test Test Test,T...est Test Test Test Test,Test Test Test Test Test T...test More test More test More test More test More ...test More test More test More test More,test More ...
(Date:11/21/2009)... HAPPYneuron,s most popular and addic...one and iPod Touch. , Mou...euron,s most popular and addictive game, SplitWord...Split Words is designed to help banish that ,tip o...s iPhone brain game challenges the brain by enco...
(Date:11/21/2009)... Linwood Group ask whether there is a...easured? , London, UK (PR...t with up to one in three of the adult UK populati...eloping alcohol-related liver disease*, it is hard...o rehabilitation programmes and residential centre...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4
...placed an order for a stock of GlaxoSmithKline Plc... to protect its entire population.// According...ederal Office of Public Health had ordered 8 milli...gulatory file for the pre-pandemic vaccine by the ...
...number of chemotherapy patients has increased the ... requested to donate platelets.// According ...sh Cancer Society (ICS), in the last 5 years, ther... platelets every year. The Irish hospitals receive...
...al use for decades, a small, sweet-tasting compoun... cure for epilepsy.// 2-deoxy-glucose, or 2D...canning and cancer imaging studies in humans. But ... Reported in the journal Nature Neuroscience, the ...
...an earlier discovery that a gene called IRF6 is in...late, researchers at the University of Iowa Roy J....heir colleagues have identified the function of th...ells, a discovery that may have implications for w...
... home care for several thousands of elderly people...ors.// According to the Commission for Social ...re givers too rushed, giving insufficient time to ...". The government said that although there had bee...
...overnment-sponsored reports released on Tuesday re... spite of the risks due to contamination. These re... "Overall, for major health outcomes among adu...tructor in epidemiology at the Harvard School of P...
Other Medicine News:Health News:Chemotherapy increases the demand for blood components 2Health News:Commonplace Sugar Compound Silences Seizures 2Health News:Commonplace Sugar Compound Silences Seizures 3Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 2Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 3Health News:Standards of Home Care for Elderly Needs Change 2Health News:Eating Fish has more Benefits than Risks 2
(Date:11/20/2009)...Y, N.C., Nov. 20 Corners...ty pharmaceutical company focused on acquiring, de...primarily for the respiratory and related markets,...ter from the Food and Drug Administration ("FDA") ...enylephrine HCl 10 mg, Pyrilamine Maleate 16 mg) a...
(Date:11/20/2009)...WOOD, Ill., Nov. 20 /PRNewswire-FirstCall/ -- L...sults for the fiscal fourth quarter and full year ..., The company will host a conference call for i.... Eastern Time. Investors may access the live call... and Canada), or 480-629-9835 (international calle...
(Date:11/20/2009)...RRISBURG, Pa., Nov. 20 ...e H1N1 flu shots to members of priority groups tha..., A total of 18 clinics are being held statewide ...m. to 8 p.m. Hours on Saturday, Nov. 21, will be 8...ll operate from 2 p.m. to 8 p.m. ,, Individual...
Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Blue Cross Blue Shield of Michigan Releases Letter Sent to Congressmen John Dingell and Sander Levin 55052 1Blue Cross Blue Shield of Michigan Releases Letter Sent to Congressmen John Dingell and Sander Levin 55052 2Blue Cross Blue Shield of Michigan Releases Letter Sent to Congressmen John Dingell and Sander Levin 55052 3Blue Cross Blue Shield of Michigan Releases Letter Sent to Congressmen John Dingell and Sander Levin 55052 4Gene Linked to Inherited Kidney Disease Found 55049 1Swine Flu Vaccine Seems Safe in Early Trials 55046 1Swine Flu Vaccine Seems Safe in Early Trials 55046 2Swine Flu Vaccine Seems Safe in Early Trials 55046 3
...rnational Conference on Antiviral,Research, SAN DI...RX,Pharmaceuticals, Inc. , a biopharmaceutical res...lizing proprietary product,candidates for the trea... today that it presented results demonstrating syn...a (bird flu) viruses when,the Company,s broad-spec...
...--May 4, 2007 - New data have,demonstrated that re...ts treated with COPAXONE(R) (glatiramer acetate in...toxantrone experienced a,90 percent reduction in m...activity compared to their baseline. These benefit...hout the 24-month study,period. These long-term da...
Other Medicine Technology:ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 2ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7
Troutman-Barraquer Corneal Utility Forceps, Colibri Style - 0.5 mm
Catalano Corneal Scleral Forceps
Troutman-Barraquer Corneal Utility Forceps, Colibri Style
Colibri Forceps 0.12 mm
Medicine Products: